Journal for ImmunoTherapy of Cancer (Nov 2023)

442-N RNA primed SMAR-TTM cells against multiple driver mutations, all HLA’s, designed for first line therapy

  • Walter Barry,
  • Farzonai Muzaffar,
  • Sriram Srivatsa,
  • Ground Entrance,
  • Ryan Campbell,
  • Abenezer Abera,
  • Alfred E Slanetz

DOI
https://doi.org/10.1136/jitc-2023-SITC2023.0442-N
Journal volume & issue
Vol. 11, no. Suppl 2

Abstract

Read online

No abstracts available.